Using immunohistochemistry assay, it has been reported that ING2 protein expression was decreased in patients with, melanoma, breast cancer, hepatocellular carcinoma (16/29 and 44/84) and osteosarcoma [43,44,45]. The gene discussed is ING2; the disease is hepatocellular carcinoma.